Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the diabetes prevention program

Diabetes Care

Volumn 35, Issue 2, 2012, Pages 363-366

  Delahanty, Linda M ^a,b   Pan, Qing ^c   Jablonski, Kathleen A ^c   Watson, Karol E ^d   McCaffery, Jeanne M ^e   Shuldiner, Alan ^f   Kahn, Steven E ^g   Knowler, William C ^h   Florez, Jose C ^a,b,i   Franks, Paul W ^j,k  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁱ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^j LUND UNIVERSITY HOSPITAL   (Sweden)

^k HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METFORMIN; PLACEBO;

ALLELE; ARTICLE; BDNF GENE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ETV5 GENE; FAIM2 GENE; FTO GENE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GNPDA2 GENE; HEALTH PROGRAM; HUMAN; KTCD15 GENE; LIFESTYLE MODIFICATION; LYPLAL1 GENE; MAJOR CLINICAL STUDY; MC4R GENE; MSRA GENE; MTCH2 GENE; NEGR1 GENE; PPARG GENE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SEC16B GENE; SH2B1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TFAP2B GENE; TMEM18 GENE; TREATMENT RESPONSE; WEIGHT GAIN; WEIGHT REDUCTION;

BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL ADHESION MOLECULES, NEURONAL; DIABETES MELLITUS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GPI-LINKED PROTEINS; HUMANS; LIFE STYLE; LYSOPHOSPHOLIPASE; MEMBRANE PROTEINS; METFORMIN; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; PROTEINS; WEIGHT GAIN; WEIGHT LOSS;

EID: 84858273254     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1328     Document Type: Article

References (12)

1. Lindgren CM, Heid IM, Randall JC, et al.; Wellcome Trust Case Control Consortium; Procardis Consortia; Giant Consortium. Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet 2009;5:e1000508
2. Willer CJ, Speliotes EK, Loos RJ, et al.; Wellcome Trust Case Control Consortium; Genetic Investigation of ANthropometric Traits Consortium. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet 2009;41: 25-34
3. Li S, Zhao JH, Luan J, et al. Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study. PLoS Med 2010;7:e1000332
4. Knowler WC, Barrett-Connor E, Fowler SE, et al.; Diabetes Prevention Program Research Group. Reduction inthe incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
5. Rubin RR, Fujimoto WY, Marrero DG, et al.; DPP Research Group. The Diabetes Prevention Program: recruitment methods and results. Control Clin Trials 2002;23: 157-171 (Pubitemid 34273848)
6. Franks PW, Jablonski KA, Delahanty L, et al.; Diabetes Prevention Program Research Group. The Pro12Ala variant atthe peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program. Diabetologia 2007;50:2451-2460 (Pubitemid 350060645)
7. Hivert MF, Jablonski KA, Perreault L, et al.; DIAGRAM Consortium; Diabetes Prevention Program Research Group. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 2011;60:1340-1348
8. Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979;6:65-70
9. Jablonski KA, McAteer JB, de Bakker PI, et al.; Diabetes Prevention Program Research Group. Common variants in40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes 2010;59:2672-2681
10. Nicklas BJ, van Rossum EF, Berman DM, Ryan AS,Dennis KE, Shuldiner AR. Genetic variation inthe peroxisome proliferator-activated receptor-γ2 gene (Pro12Ala) affectsmetabolic responses toweight loss and subsequent weight regain. Diabetes 2001; 50:2172-2176 (Pubitemid 33643689)
11. Goyenechea E, Dolores Parra M, Alfredo Martínez J. Weight regain after slimming induced by an energy-restricted diet depends on interleukin-6 and peroxisome-proliferator- activated-receptor-gamma2 gene polymorphisms. Br J Nutr 2006;96: 965-972 (Pubitemid 46454576)
12. Vogels N, Mariman EC, Bouwman FG, Kester AD, Diepvens K, Westerterp- Plantenga MS. Relation of weight maintenance and dietary restraint to peroxisome proliferator-activated receptor gamma2, glucocorticoid receptor, and ciliary neurotrophic factor polymorphisms. Am J Clin Nutr 2005;82:740-746 (Pubitemid 43779685)